Strain Name: |
FVB/N-Tg(Eno2CDK5R1)1Jdm/J |
|---|---|
Stock Number: |
003753 |
Availability: | Repository-Cryopreserved |
General Terms and Conditions |
| Genes & Alleles | CDK5R1; Eno2; Tg(Eno2CDK5R1)1Jdm; |
Type JAX® GEMM® Strain - Mutant Strain Additional information on JAX® GEMM® Strains. Type JAX® GEMM® Strain - Transgenic Species laboratory mouse Donating Investigator Michael Ahlijanian, Pfizer Central Research Strain Description
These transgenic animals display a robust expression of the amino terminal proteolytic fragment p25 of human CDK5R1. Expression is detected in the amygdala, thalamus/hypothalamus, cerebral cortex, and cerebellum. The p25 fragment acts as a positive allosteric regulator of cyclin-dependent kinase 5 (Cdk5), a kinase known to phosphorylate the microtubule-binding protein tau. A two-fold increase in the catalytic activity of Cdk5 is observed in these mice. In contrast to wildtype control mice, brains from 4-month-old exhibit the presence of tau and neurofilament phosphoepitopes. Utlrastructurally, axonal swelling in neurons from the amygdala and spinal cord is observed. Affected neurons possess numerous, abnormally clustered mitochondria and lysosomes, with some evidence of cytoskeletal disorganization. Mice exhibit whole-body tremors at 4-9 weeks of age and enhanced open-field locomotor activity. Aspects of this phenotype are similar to Alzheimer's, Pick's and other neurodegenerative diseases.
Mammalian Phenotype Terms assigned by genotype |
| Allele Symbol | Tg(Eno2CDK5R1)1Jdm | ||
|---|---|---|---|
| Allele Name | transgene insertion 1, John D McNeish | ||
| Common Name(s) | NSE-p25 line A; P25; | ||
| Mutation Made By | John McNeish, Pfizer Central Research | ||
| Expressed Gene | CDK5R1, cyclin-dependent kinase 5, regulatory subunit 1 (p35), human | ||
| Promoter | Eno2, enolase 2, gamma, neuronal, rat | ||
| General Note | A two-fold increase in the catalytic activity of Cdk5 is observed in transgenic mice. In contrast to wild type control mice, brains from 4-month-old exhibit the presence of tau and neurofilament phosphoepitopes. Ultrastructurally, axonal swelling in neurons from the amygdala and spinal cord is observed. Affected neurons possess numerous, abnormally clustered mitochondria and lysosomes, with some evidence of cytoskeletal disorganization. Mice exhibit whole-body tremors at 4-9 weeks of age and enhanced open field locomotor activity. | ||
| Molecular Note | The transgene contains rat enolase 2, gamma neuronal (Eno2) promoter sequence and human cyclin-dependent kinase 5, regulatory subunit 1 sequence (CDK5R1) encoding the amino terminal proteolytic fragment p25. Robust expression of the transgenic fragment 25 is detected in the amygdala, thalamus/hypothalamus, cerebral cortex, and cerebellum. [MGI Ref ID J:82825] | ||
| Control | ||
|---|---|---|
| 001800 FVB/NJ | ||
| Considerations for Choosing Controls | ||
Tg(Eno2CDK5R1)1Jdm
| Breeding & Husbandry | The donating investigator maintains this strain as a homozygote on a FVB/N background (N6). |
|---|
Strains carrying other alleles of CDK5R1
005706 C57BL/6-Tg(tetO-CDK5R1/GFP)337Lht/J View Strains carrying other alleles of CDK5R1 (1 strain)
Strains carrying other alleles of Eno2
003833 B6.Cg-Tg(Eno2-Ighmpb2)17Cx Ighmbp2nmd-2J/Cx 006663 B6.Cg-Tg(Eno2-cre)39Jme/J 003767 B6.Cg-Tg(Eno2tTA)5021Nes/J 003763 B6.Cg-Tg(Eno2tTA)5030Nes/J 004360 B6;SJL-Tg(HD)63Aron/J 007860 C57BL/6J-Tg(Eno2-YFP/Cox8a)ZRwb/J 006297 FVB.Cg-Tg(Eno2-cre)39Jme/J 005938 STOCK Tg(Eno2-cre)39Jme/J View Strains carrying other alleles of Eno2 (8 strains)
Visit the Alzheimer's Disease Mouse Model Resource site for helpful information on Alzheimer's Disease and research resources.
Neurobiology Research
Alzheimer's Disease
Neurodegeneration
Tremor Defects
| Strain Name: | FVB/N-Tg(Eno2CDK5R1)1Jdm/J |
| Stock Number: | 003753 |
IMPORTANT NOTE: Prices are based on shipping destination. To view prices, select your shipping destination.
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
Cryorecovery - Standard. The recovery process begins when a signed agreement form is returned to the Customer Service Department after order placement. Although results vary by strain, at least two males and two females (two pairs) will be provided, typically within 15 weeks of our receipt of the signed agreement form. If the first recovery attempt is unsuccessful or only one pair is recovered, a second recovery will be done, extending the delivery time to approximately 25 weeks. At least one member of each pair will be of known genotype and will carry the mutation if it is a mutant strain. Please note that pairs may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation of the strain. Mating schemes are sometimes modified for successful cryopreservation. Price represents a repository maintenance fee, which includes the cost of recovery of the strain from the cryopreservation resource and the periodic replacement of the frozen embryos used for recovery. Cryorecovery to establish a Dedicated Supply for greater quantities of mice. |
| Licensing | See General Terms and Conditions below for Licensing and Use Restrictions |
| Control Information | View Control Information in Strain Details. |
For additional Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form